📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetically proxied inhibition of tumor necrosis factor and the risk of colorectal cancer: A drug-target mendelian randomization study. (2022)

First Author: Chen M

Attributed to: UK Biobank (core renewal) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2022.1079953

PubMed Identifier: 36618924

Publication URI: http://europepmc.org/abstract/MED/36618924

Type: Journal Article/Review

Volume: 13

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812